Expansion in China Natus has recently expanded manufacturing capabilities with a new facility in Suzhou for the Nicolet EDX system, and has launched locally manufactured EMG solutions in China, signaling a strategic entry point for accelerated sales and service support in the PRC with potential channel partnerships and localized pricing.

AI-Enhanced Diagnostics Recent product updates include autoSCORE AI-supported EEG interpretation and AVEMG in the Natus Elite EMG software, presenting opportunities to upsell AI-driven analysis tools to existing neurodiagnostic customers and to integrate with hospital AI initiatives.

Integrated Neuro Diagnostics Natus offers a broad portfolio across EEG, EMG, ICU monitoring, ICP, and external ventricular drainage, enabling cross-sell opportunities to neurodiagnostic labs, ICUs, and neurology departments seeking an integrated platform rather than single-discipline solutions.

Strategic Acquisitions The acquisition of Holberg EEG and ongoing competitive positioning suggest a momentum in AI and neurodiagnostic innovation, which can be leveraged to position Natus as a value-added partner against rivals and to pursue cross-border and enterprise contracts.

Global Enterprise Focus With a revenue range of 50–100 million and a global footprint implied by partnerships and press coverage, there is a clear opportunity to target large hospital systems and regional distributors for multi-site deployments, extended service contracts, and scalable training programs.